22 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
1995886	15	Structure-activity relationship of quinazolinedione inhibitors of calcium-independent phosphodiesterase.	Pfizer
1825116	36	Nicotinamide ethers: novel inhibitors of calcium-independent phosphodiesterase and [3H]rolipram binding.	Pfizer
1992129	27	Calcium-independent phosphodiesterase inhibitors as putative antidepressants: [3-(bicycloalkyloxy)-4-methoxyphenyl]-2-imidazolidinones.	Pfizer
6161252	3	Substituted 6,7-dihydroimidazo[1,2-a]purin-9(4H)-ones.	TBA
12824033	30	Improvement of therapeutic index of phosphodiesterase type IV inhibitors as anti-Asthmatics.	Lead Gene
11814830	26	7-Methoxyfuro[2,3-c]pyridine-4-carboxamides as PDE4 inhibitors: a potential treatment for asthma.	Celltech R&D
12039576	17	Synthesis and profile of SCH351591, a novel PDE4 inhibitor.	Schering-Plough
12039575	18	8-Methoxyquinolines as PDE4 inhibitors.	Schering-Plough
12039574	16	8-Methoxyquinoline-5-carboxamides as PDE4 inhibitors: a potential treatment for asthma.	Celltech R&D
11266153	32	Syntheses and evaluation of pyrido[2,3-dlpyrimidine-2,4-diones as PDE 4 inhibitors.	Korea Institute of Science and Technology
11128646	69	Synthesis and biological evaluation of 2,5-dihydropyrazol.	RhôNe-Poulenc Rorer
10999488	34	7-Methoxybenzofuran-4-carboxamides as PDE 4 inhibitors: a potential treatment for asthma.	Celltech-Chiroscience
10636238	71	Synthesis and structure-activity relationships of 4-oxo-1-phenyl-3,4,6,7-tetrahydro-[1,4]diazepino[6,7,1-hi]indoles: novel PDE4 inhibitors.	Institut De Recherche Jouveinal-Parke Davis
11844693	35	Synthesis and biological evaluation of imidazol-2-one and 2-cyanoiminoimidazole derivatives: novel series of PDE4 inhibitors.	Janssen-Cilag
12161123	13	A prenylated flavonol, sophoflavescenol: a potent and selective inhibitor of cGMP phosphodiesterase 5.	Korea Institute of Science & Technology
15125967	30	Identification of purine inhibitors of phosphodiesterase 7 (PDE7).	Bristol-Myers Squibb Pharmaceutical Research Institute
9873643	75	Quinazolines: combined type 3 and 4 phosphodiesterase inhibitors.	Novartis Pharma
11123995	113	Synthesis, structure-activity relationships, and pharmacological profile of 9-amino-4-oxo-1-phenyl-3,4,6,7-tetrahydro[1,4]diazepino[6, 7,1-hi]indoles: discovery of potent, selective phosphodiesterase type 4 inhibitors.	Pfizer
9526558	38	1,4-Cyclohexanecarboxylates: potent and selective inhibitors of phosophodiesterase 4 for the treatment of asthma.	Smithkline Beecham Pharmaceuticals
9767640	122	Design, synthesis, and biological activities of new thieno[3,2-d] pyrimidines as selective type 4 phosphodiesterase inhibitors.	RhôNe-Poulenc Rorer
9154964	25	Novel heterocyclic-fused pyridazinones as potent and selective phosphodiesterase IV inhibitors.	Dipartimento Di Scienze Farmaceutiche, Firenze, Italy.